1. Home
  2. MRLN vs TNYA Comparison

MRLN vs TNYA Comparison

Compare MRLN & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Merlin Inc. Common Stock

MRLN

Merlin Inc. Common Stock

HOLD

Current Price

$0.87

Market Cap

172.8M

Sector

Technology

ML Signal

HOLD

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.42

Market Cap

153.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRLN
TNYA
Founded
2018
2016
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
172.8M
153.2M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
MRLN
TNYA
Price
$0.87
$0.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
6
Target Price
★ $7.92
$3.20
AVG Volume (30 Days)
2.5M
★ 3.8M
Earning Date
11-12-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 54.96
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
$9.23
N/A
Revenue Next Year
$153.29
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.82
$0.36
52 Week High
$17.00
$1.56

Technical Indicators

Market Signals
Indicator
MRLN
TNYA
Relative Strength Index (RSI) 21.28 34.29
Support Level N/A $0.36
Resistance Level $3.45 $0.80
Average True Range (ATR) 0.12 0.04
MACD 0.02 -0.00
Stochastic Oscillator 7.46 24.96

Price Performance

Historical Comparison
MRLN
TNYA

About MRLN Merlin Inc. Common Stock

Merlin Inc develops software that fulfills the functions of a human pilot in self-flying aircraft to enable both reduced crew and unmanned flight. This technology is designed to be scalable and adaptable across different aircraft types for a growing range of aircraft platforms. The company's aircraft-agnostic, AI-powered software is purpose-built for military and civil programs, and is powering an expanding range of missions and aircraft, through hundreds of autonomous flights from test facilities across the globe. It operates as a single operating and reportable segment.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: